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ABSTRAK
Latar belakang: sarcopenia merupakan salah satu masalah geriatri yang menimbulkan dampak luaran klinis 
yang besar. Lingkar betis dan paha berkorelasi kuat dengan massa otot, sedangkan kuesioner SARC-F merupakan 
prediktor fungsi otot. Belum ada studi yang mengevaluasi performa diagnostik kombinasi lingkar betis dan paha 
dengan kuesioner SARC-F untuk mendeteksi sarcopenia. Penelitian ini bertujuan untuk mengevaluasi performa 
diagnostik kombinasi lingkar betis dan paha dengan kuesioner SARC-F dibandingkan dengan metode diagnostik 
sarcopenia menurut the Asian Working Group for Sarcopenia (AWGS) untuk memprediksi sarcopenia pada pasien 
berusia 60 tahun atau lebih. Metode: studi potong lintang dilaksanakan di klinik geriatri Rumah Sakit Cipto 
Mangunkusumo, Jakarta, Indonesia selama periode April hingga Juni 2018. Analisis dilakukan sesuai kurva 
receiver operating characteristic (ROC) untuk menentukan titik potong beserta nilai sensitivitas dan spesifisitas, 
nilai duga positif dan negatif, rasio kemungkinan positif dan negatif lingkar betis dan paha sebagai acuan massa 
otot yang rendah, serta skor kuesioner SARC-F untuk mendeteksi penurunan fungsi otot. Hasil: sebanyak 74 dari 
120 (61,7%) subjek penelitian adalah perempuan. Kombinasi lingkar betis dengan titik potong <34 cm pada 
lelaki dan <29 cm pada perempuan serta lingkar paha <49 cm pada lelaki dan <44 cm pada perempuan dengan 
skor kuesioner SARC-F ≥4 memiliki nilai sensitivitas dan spesifisitas, nilai duga positif dan negatif serta rasio 
kemungkinan positif dan negatif berturut-turut sebesar 15,79%; 99,01%; 75,00%; 86,21%; 15,95; and 0,85. 
Kesimpulan: kombinasi lingkar betis dan paha dengan kuesioner SARC-F memiliki akurasi diagnostik yang baik 
dalam memprediksi sarcopenia pada pasien lanjut usia.
Kata kunci: kuesioner SARC-F, lanjut usia, lingkar betis, lingkar paha, sarcopenia 
ABSTRACT
Background: sarcopenia is one of many geriatric problems that may lead to major clinical outcomes. Calf and 
thigh circumference have good correlation with muscle mass, whereas SARC-F questionnaire is very predictive of 
muscle function. There has not been a study that evaluates the diagnostic performance of calf and thigh circumference 
in combination with SARC-F questionnaire in detecting sarcopenia. The aim of this study was to investigate the 
diagnostic performance of calf and thigh circumference in combination with SARC-F questionnaire compared 
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to standard diagnostic methods of sarcopenia according to the Asian Working Group for Sarcopenia (AWGS) to 
predict sarcopenia in patient aged 60 years or older. Methods: this cross-sectional study was conducted in Geriatric 
Clinic Cipto Mangunkusumo Hospital, Jakarta, Indonesia during April–June 2018. Analysis was performed using 
receiver operating characteristic (ROC) curve to determine the cut-off point as well as sensitivity (Sn), specificity 
(Sp), positive and negative predictive value (PPV and NPV), positive and negative likelihood ratio (LR+ and LR-) 
of calf and thigh circumference as an indicator of low muscle mass, and SARC-F questionnaire score to detect 
decreased muscle function. Results: from 120 participants, there were 46 men (38.3%) and 74 women (61.7%). 
The combination of calf circumference with cut-off point below 34 cm in men and below 29 cm in women, thigh 
circumference below 49 cm in men and below 44 cm in women with SARC-F questionnaire score of ≥4 have Sn, 
Sp, PPV, NPV, LR+, and LR- of 15.79%; 99.01%; 75.00%; 86.21%; 15.95; and 0.85 respectively. Conclusion: 
combination of calf and thigh circumference with SARC-F questionnaire showed good diagnostic accuracy in 
predicting sarcopenia in elderly outpatients.
Keywords: calf circumference, elderly, thigh circumference, SARC-F questionnaire, sarcopenia.
INTRODUCTION
The number of older people in Asia, including 
Indonesia as well as globally, are increasing every 
year.1 This increase may impose a health burden 
when the proportion of frail individuals within 
the older people population is also increasing. 
Beside frailty, sarcopenia is another important 
health problem that is commonly found in elderly. 
Sarcopenia is defined as age-related decrease in 
muscle mass as well as decline in muscle function, 
characterized by decrease in muscle strength 
and/or physical performance.2-4 Sarcopenia is 
associated with dependency,5,6 decreased cognitive 
and cardiopulmonary function,7-10 falls,11 lower 
quality of life, mortality,12-16 and high health 
costs.17 Sarcopenia is a treatable condition and 
early intervention can improve the clinical 
outcomes, thus rapid identification is important 
in the management of sarcopenia. Based on 
the definition, diagnosis of sarcopenia requires 
measurement of muscle mass, muscle strength, and 
physical performance. However, such diagnostic 
approach is time consuming, expensive, and 
requires trained personnel. Therefore, a simple 
method to rapidly diagnose sarcopenia will be a 
very valuable tool, especially for health personnel 
with limited access to facilities.
SARC-F questionnaire is a tool to diagnose 
sarcopenia quickly. It consists of questions 
regarding strength, assistance with walking, ability 
to rise from chair and climb stairs, as well as falls. 
SARC-F score ≥ 4 is indicative of sarcopenia and 
poor clinical outcome. A number of studies have 
shown that the SARC-F questionnaire showed 
comparable performance with the European 
Working Group on Sarcopenia in Older People 
(EWGSOP) and the Asian Working Group for 
Sarcopenia (AWGS) methods in identifying 
sarcopenia.18 In addition, SARC-F questionnaire 
is highly predictive of muscle function and its 
use has been validated in general population in 
community setting,18-20 populations with diabetes 
mellitus,21 and populations with cardiovascular 
disease.16 However, the sensitivity of the 
SARC-F questionnaire is unsatisfactory.22 In effort 
to increase the sensitivity, Barbosa-Silva et al23 
added measurement of calf circumference as the 
representation of muscle mass besides SARC-F 
questionnaire. This addition of calf circumference 
measurement besides SARC-F increased the 
sensitivity without compromising ability to detect 
sarcopenia both in community and nursing homes. 
However, the sensitivity was still unsatisfactory 
even after addition of calf circumference.23,24
In addition to calf circumference, thigh 
circumference also has a strong correlation 
with muscle mass.25 Moreover, decreased thigh 
muscle mass is associated with a decrease in 
lower limb performance as seen in walking speed 
and repeated chair stand test.26 Therefore, thigh 
circumference may also be used as a surrogate 
marker of muscle mass to diagnose sarcopenia in 
addition to calf circumference. The addition of the 
thigh circumference, beside the calf circumference 
is expected to improve diagnostic performance of 
SARC-F questionnaire. There has been a study 
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that assessed the performance of of SARC-F 
questionnaire and calf circumference combination 
compared to diagnostic criteria of sarcopenia 
based on EWGSOP. However, there has not been 
a study that investigate the diagnostic performance 
of the combination of calf and thigh circumference 
with SARC-F questionnaire to detect sarcopenia. 
Therefore, this study was aimed to investigate the 
diagnostic performance of combination of calf and 
thigh circumference with SARC-F questionnaire 
compared to diagnostic methods of sarcopenia 
from AWGS to predict sarcopenia in patient aged 
60 years or older.
METHODS
This cross-sectional study was approved by 
the Ethical Committee of Faculty of Medicine 
Universitas Indonesia/ Cipto Mangunkusumo 
Hospital (No. 0137/UN.2F1/ETIK/2018) and 
was conducted in April–June 2018 at the Geriatric 
Clinic of Cipto Mangunkusumo Hospital, 
Jakarta, Indonesia. We recruited patients aged 
60 years and older consecutively. Those who 
had acute cardiovascular or respiratory diseases, 
cognitive impairment (Abbreviated Mental Test 
<8), body weight >100 kg, Parkinson’s disease or 
other conditions with symptoms of tremor, limb 
edema and/ or amputation, artificial implants, 
as well as inability to walk or to lie down in flat 
position, unwilling to take part in this study, and 
uncooperative were excluded.
Anthropometric measurements were 
performed using non-elastic bands by examiners 
who were trained in standardized measurement 
methods. The subjects stand with their feet about 
25 cm in distance in a relaxed position so that the 
body weight was evenly distributed on both legs. 
Measurements were made on the non-dominant 
side with the legs uncovered by clothes or with 
thin clothing. The thigh circumference was 
measured on the gluteal fold around the thigh in 
a horizontal position and was attached to the skin 
but did not suppress the tissue underneath. The 
calf circumference was measured by encircling 
the calf in a horizontal position and attached to 
the skin but not pressing the tissue underneath, 
then the tape was moved up and down to get the 
largest circumference. Measurements were made 
3 times and then rounded to the nearest 0.1 cm 
to get the mean value.
Handgrip strength examination was carried 
out with a calibrated JAMAR® J00105 hydraulic 
handheld dynamometer. The examination was 
performed on the dominant hand 3 times with a 
break time of 30 seconds between examinations. 
The highest value was taken as the hand-held 
muscle strength. Physical performance was 
assessed by usual walking speed at a distance of 
6 meters. Subjects were asked to walk straight as 
usual, then the time used to walk at a distance of 
6 meters were recorded by using a stopwatch and 
the usual walking speed was calculated.
Muscle mass measurements were examined 
using dual energy X-ray absorptiometry (DXA) 
at Osteoporosis Center-Medistra Hospital, 
Jakarta. Appendicular Skeletal Muscle Mass 
(ASM) was obtained by summing the soft tissue 
mass in the arms and legs, while the Skeletal 
Muscle Index (SMI) is obtained from ASM 
divided by the square of height in meters (kg/m2). 
The original SARC-F questionnaire was 
translated into Indonesian and then translated 
back into English by registered English 
translators and then verified again to maintain 
the same concept of the term used. The SARC-F 
questionnaire that has been adapted was then 
applied to the research subject (attachments 1). 
Subjects with SARC-F score ≥4 were considered 
sarcopenia. The diagnosis of sarcopenia was 
established based on the criteria set by AWGS, 
which were low muscle mass (SMI <7.0 kg/m2 
for men and <5.4 kg/m2 for women) plus low 
function muscle (hand held strength <26 kg in 
men and <18 kg in women and/ or walking speed 
<0.8 m/second for both sexes).
Statistical Analysis
Data analysis was performed using Statistical 
Package for the Social Sciences (SPSS) program 
version 20.0. The statistical power was set at 
80%, whereas 5% for the α value. The minimum 
sample size was 86 subjects. Categorical data was 
presented in numbers and percentages. Numerical 
data was presented in the mean (standard 
deviation) if the data distribution was normal 
and median (minimum–maximum) values if the 
data distribution was not normal. Value of Area 
Under the Curve (AUC) as well as cut-off point of 
calf and thigh circumference, and SARC-F score 
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were determined based on Receiver Operating 
Characteristics (ROC) curves. The cut-off points 
were then processed into dichotomous categorical 
variables, combined, and compared with the 
diagnosis of sarcopenia based on AWGS criteria 
Table 1. Baseline characteristics of study participants
Variables Male (n=46) Female (n=74) Total  (N=120)
Age (years)a 72.41 (6.83) 71.57 (5.64) 71.89 (6.11)
Levels of education, n (%)
 - Low 4 (8.7) 15 (20.3) 19 (15.8)
 - Middle 13 (28.3) 27 (36.5) 40 (33.3)
 - High 29 (63.0) 32 (43.2) 61 (50.9)
Body Mass Index (kg/m2)a 21.87 (3.84) 22.88 (4.98)
Body Mass Index group, n (%)
 - Underweight 10 (21.7) 15 (20.3) 25 (20.8)
 - Normal 20 (43.5) 25 (33.8) 45 (37.5)
 - Overweight 5 (10.9) 7 (9.5) 12 (10)
 - Obese I 10 (21.7) 22 (29.7) 32 (26.7)
 - Obese II 1 (2.2) 5 (5) 6 (5)
Comorbidity, n (%)
 - Diabetes mellitus 20 (43.5) 22 (29.7) 42 (35)
 - Hypertension 36 (78.3) 61 (82.4) 97 (80.8)
 - Chronic Heart Failure 16 (34.8) 15 (20.3) 31 (25.8)
 - Cerebrovascular Disease 13 (28.3) 7 (9.5) 20 (16.7)
 - Chronic Kidney Disease 11 (23.9) 6 (8.1) 17 (14.2)
 - Chronic Liver Disease 3 (6.5) 8 (10.8) 11 (9.2)
 - Asthma/ COPD 3 (6.5) 7 (9.5) 10 (8.3)
 - Malignancy 0 (0) 3 (4.1) 3 (2.5)
 - Skeletal Muscle Index (kg/m2)a 7.45 (0.91) 6.53 (0.82)
Muscle mass status,* n (%)
 - Low 17 (37) 7 (9.5) 24 (20)
 - Normal 29 (63) 67 (90.5) 96 (80)
 - Hand grip strength (kg)a 26.13 (6.24) 18 (10–35)b
Hand grip strength status,* n (%)
 - Low 18 (39.1) 34 (45.9) 52 (43.3)
 - Normal 28 (60.9) 40 (54.1) 68 (56.7)
 - Walking speed (meter/second)a 0.78 (0.22) 0.75 (0.23)
Walking speed status,* n (%)
 - Low 28 (60.9) 40 (54.1) 68 (56.7)
 - Normal 18 (39.1) 34 (45.9) 52 (43.3)
 - Calf circumference (cm)a 35.29 (3.78) 34.42 (4.68)
 - Thigh circumference (cm)a 51.75 (6.10) 52.92 (8.87)
 - SARC-F scoreb 1 (0–7) 2 (0–8)
Sarcopenia status,* n (%)
 - Sarcopenia 14 (30.4) 5 (6.8) 19 (15.8)
 - No sarcopenia 32 (69.6) 69 (93.2) 101 (84.2)
* : based on the diagnosis criteria of sarcopenia from Asian Working Group for Sarcopenia;
a : mean (standard deviation); b : median (minimal-maximal); COPD: Chronic Obstructive Pulmonary Disease
using a 2x2 table. Based on the analysis of the 2x2 
table, sensitivity (Sn), specificity (Sp), positive 
predictive value (PPV), negative predictive value 
(NPV), positive likelihood ratio (LR+), and 
negative likelihood ratio (LR-) were obtained.
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RESULTS
There were 142 subjects who met the 
inclusion criteria and 22 subjects who did not, 
so that a total of 120 subjects were analyzed. The 
basic characteristics of the subject in this study 
can be seen in Table 1. Of the 120 subjects who 
participated in this study, there were 46 men 
(38.3%) and 74 women (61.7%). The mean age 
of all subjects was 71.89 (6.11) years with a mean 
age of 72.41 (6.83) years in the male subjects 
and 71.57 (5.64) years in the female subjects. 
The proportion of subjects with body mass 
index (BMI) categories of underweight, normal, 
overweight, obese I, and obese II were 20.8%, 
37.5%, 10%, 26.7%, and 5% respectively. The 
most comorbidities obtained were hypertension 
(80.8%), diabetes mellitus (35%), chronic 
heart failure (25.8%), cerebrovascular disease 
(16.7%), chronic kidney disease (14.2%), 
chronic liver disease (9.2%), asthma/ COPD 
(8.3%), and malignancy (2.5%). The proportion 
of subjects with decreased muscle mass was 
20%, with the proportion of male subjects was 
higher than female subjects (37% vs. 9.5%). 
The proportion of subjects with low handgrip 
strength was 43.3%, with the proportion of 
female subjects was higher than male subjects 
(45.9% vs. 39.1%). The proportion of subjects 
Table 2. Characteristics of the subjects based on gender and sarcopenia status according to AWGS criteria
Variables
Male (n = 46) Female (n = 74) Total (N = 120)
Sarcopenia 
(n =14)
No sarcopenia 
(n = 32)
Sarcopenia
(n = 5)
No sarcopenia
(n = 69)
Sarcopenia
(n = 19)
No sarcopenia
(n = 101)
Age (years)a 78.36 (5.44) 69.81 (5.68) 76.4 (4.04) 71.22 (5.60) 77.84 (5.08) 70.77 (5.64)
Body Mass Index, n (%)
 - Underweight 7 (15.2) 3 (6.5) 4 (5.4) 11 (14.9) 11 (9.2) 14 (11.7)
 - Normal 6 (13.0) 14 (30.4) 1 (1.4) 24 (32.4) 7 (5.8) 38 (31.7)
 - Overweight 1 (2.2) 4 (8.7) 0 (0) 7 (9.5) 1 (0.8) 11 (9.2)
 - Obese I 0 (0) 10 (21.7) 0 (0) 22 (29.7) 0 (0) 32 (26.7)
 - Obese II 0 (0) 1 (2.2) 0 (0) 5 (6.8) 0 (0) 6 (5)
Body Mass Index (kg/
m2)a 18.81 (2.85) 23.22 (3.44) 16.71 (1.91) 23.32 (4.84) 18.26 (2.75) 23.29 (4.43)
Comorbidity, n (%)
 - Hypertension 11 (23.9) 25 (54.3) 3 (4.1) 58 (78.4) 14 (11.7) 83 (69.2)
 - Diabetes Mellitus 7 (15.2) 13 (28.3) 2 (2.7) 20 (27) 9 (7.5) 33 (27.5)
 - Chronic Heart 
Failure 5 (10.9) 11 (23.9) 0 (0) 15 (20.3) 5 (4.2) 26 (21.7)
 - Chronic Kidney 
Disease 6 (13.0) 5 (10.9) 0 (0) 6 (8.1) 6 (5.0) 11 (9.2)
 - Cerebrovascular 
Disease 4 (8.7) 9 (19.6) 0 (0) 7 (9.5) 4 (3.3) 16 (13.3)
 - Chronic Liver 
Disease 0 (0) 3 (6.5) 0 (0) 8 (10.8) 0 (0) 11 (9.2)
Asthma/ COPD 1 (2.2) 2 (4.3) 1 (1.4) 6 (8.1) 2 (1.7) 8 (6.7)
 - Malignancy 0 (0) 0 (0) 0 (0) 3 (100) 0 (0) 3 (2.5)
Calf circumference 
(cm)a 33.35 (4.25) 36.14 (3.28) 27.71 (1.23) 34.90 (4.46)
Thigh circumference 
(cm)a 47.86 (6.62) 53.52 (4.99) 40.10 (2.70) 53.91 (8.43)
Skeletal Muscle Index 
(kg/m2)a 6.57 (0.52) 7.83 (0.76) 5.08 (0.34) 6.64 (0.74)
Handgrip strength (kg)a 22.71 (6.51) 27.63 (5.59) 16 (12–16)b 18 (10–35)b
Walking speed (meter/
second)a 0.67 (0.15) 0.83 (0.22) 0.44 (0.18) 0.77 (0.22) 0.61 (0.19) 0.79 (0.22)
SARC-F scoreb 1 (0–4) 1 (0–7) 5 (2–6) 2 (0–8) 2 (0–6) 1 (0–8)
a : mean (standard deviation); b : median (minimal–maximal); COPD : Chronic Obstructive Pulmonary Disease.
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with low usual walking speed was found to be 
56.7%, with the proportion of male subjects was 
higher than female subjects (60.9% vs 54.1%). 
In this study, the proportion of sarcopenia was 
15.8%, with higher proportion was found in male 
subjects compared to female subjects (30.4% vs 
6.8%). The differences in the characteristics of 
the subjects in the sarcopenia and non-sarcopenia 
groups by gender can be seen in Table 2.
We performed analysis on ROC curve 
to obtain the calf circumference and thigh 
circumference cut-off points to detect low 
muscle mass as a component of the diagnosis of 
sarcopenia (Figure 1). Based on the ROC curve 
analysis, the AUC value of calf circumference 
was 73.1% in the male subjects (95% CI 57.0–
89.2, p = 0.009) and 96.4% in the female subject 
(95% CI 0.92–1.00, p<0.001). Statistically 
optimal calf circumference cut-off points were 35 
cm for male subjects with sensitivity, specificity, 
PPV, NPV, LR+, LR-, and AUC respectively 
at 70.6%, 72.4%, 60%, 80%, 8%, 2.56, 0.41, 
and 0.72; and 30 cm for female subjects with 
sensitivity, specificity, PPV, NPV, LR+, LR-, 
and AUC respectively at 85.7%, 88.1%, 42.9%, 
98.3%, 7.17, 0.16 and 0.87. In order to obtain 
a higher specificity value, we set the lower calf 
circumference cut-off points at <34 cm in male 
subjects with sensitivity, specificity, PPV, NPV, 
LR+, LR-, and AUC respectively were 64.7%, 
79.3%, 64.7%, 79.3%, 3.13, 0.45 and 0.72; 
and <29 in female subjects cm with sensitivity, 
specificity, PPV, NPV, LR+, LR-, and AUC 
respectively were 71.4%, 95.5%, 62.5%, 97%, 
15.87, 0 , 30, and 0.84.
Based on the ROC curve analysis, the AUC 
Figure 1. ROC Curve Analysis. Calf Circumference in Male Group (A) and Female Group (B); and Thigh 
Circumference in Male Group (C) and Female Group (D).
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value of the thigh circumference was 78.1% in 
the male subjects (95%CI 63.6–92.6, p=0.002) 
and 95.7% in the female subjects (95%CI 
0.91–1.00, p<0.001). The statistically optimal 
thigh circumference cut-off point were 52 cm for 
male subjects with sensitivity, specificity, PPV, 
NPV, LR+, LR-, and AUC respectively at 70.6%, 
72.4%, 60%, 80 , 8%, 2.56, 0.41, 0.72; and 44 cm 
for female subjects with sensitivity, specificity, 
PPV, NPV, LR+, LR-, and AUC respectively at 
85.7%, 94%, 60%, 98.4, 14.28, 0.15, and 0.90. 
The diagnostic values for female subjects were 
quite good. However, in order to obtain a higher 
specificity value for male subjects, we set the 
Figure 2. Comparison of ROC Curve Analysis. A. SARC-F to Muscle Function. B. SARC-F to Diagnose Sarcopenia According 
to AWGS. C. Combination of Calf Circumference and SARC-F. D. Combination of Thigh Circumference and SARC-F. E. 
Combination of Calf Circumference, Thigh Circumference and SARC-F.
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lower thigh circumference cut-off at <49 cm with 
sensitivity, specificity, PPV, NPV, LR+, LR-, and 
AUC were 64.7%, 89,7%, 78.6%, 81.3%, 6.25, 
0.39 and 0.77 respectively. We used the same 
cut–off that was considered optimal for thigh 
circumference in female subjects which were 
below 44 cm. The value of diagnostic accuracy 
of various cutting points can be seen in the table 
in Appendix 2 (http://actamedindones.org/index.
php/ijim/editor/proofGalley/976/356).
Analysis of ROC curve of SARC-F 
questionnaire was performed both on muscle 
function and the diagnosis of sarcopenia based 
on AWGS criteria (Figure 2). From this figure, 
it appears that SARC-F questionnaire is better 
at describing muscle function than the diagnosis 
of sarcopenia (AUC 0.662 vs 0.535). At the cut-
off point of SARC-F score ≥4, the sensitivity, 
specificity, PPV, NPV, LR+, LR-, and AUC were 
35.4%, 90.2%, 87.5%, 42.1%, 3.63, 0.72 and 
0.63, respectively.
A combination of calf circumference and 
SARC-F questionnaire to detect sarcopenia 
was performed using cut-off points of calf 
circumference <34 cm in male subjects and <29 
cm in female subjects to determine low muscle 
mass, and SARC-F score ≥4 to determine a 
decrease in muscle function. A combination of 
thigh circumference and SARC-F questionnaire 
to detect sarcopenia was performed using cut-
off points of thigh circumference <49 cm in 
male subjects and <44 cm in female subjects to 
determine low muscle mass, and SARC-F score 
≥4 to determine a decrease in muscle function. 
In addition, a combination of calf circumference, 
thigh circumference and SARC-F questionnaire 
to detect sarcopenia was carried out using cut-
off points of calf circumference <34 cm in male 
subjects and <29 cm in a female subject; and 
thigh circumference <49 cm in a male subject 
and <44 cm in female subjects to determine 
low muscle mass, as well as a SARC-F score 
≥4 to determine a decrease in muscle function. 
Logistic regression analysis was then carried 
out and continued with ROC curve analysis. 
Based on the ROC curve analysis, the AUC 
value of the combination of calf circumference 
and SARC-F was 79.7% (95% CI 0.67–0.92, p 
<0.001), the AUC value of the combination of 
thigh circumference and SARC-F was 80.4% 
(95% CI 0.68–0.93, p <0.001), and the AUC 
value of the combination of calf circumference, 
thigh circumference and SARC-F was 86.2% 
(95% CI 0.76–0.96, p <0.001). The curve can be 
seen in Figure 2. The comparison of diagnostic 
performance analysis of SARC-F questionnaire, 
combination of SARC-F with calf circumference, 
thigh circumference, and both can be seen in 
Table 3.
DISCUSSION
From the results above, it can be seen 
that by combining either calf circumference, 
thigh circumference, or both which represent 
muscle mass to SARC-F questionnaire that 
represents muscle function, then the ability to 
detect sarcopenia was increasing compared to 
SARC-F questionnaire alone. This appears from 
its very high specificity value of (98.02% vs. 
99.01% vs 99.01% vs. 74.26% respectively). 
However, considering the low sensitivity 
value, then combination of calf circumference, 
Table 3. Diagnostic Performance Analysis of Combination of Calf Circumference, Thigh Circumference, and SARC-F 
Questionnaire
SARC-F CC + SARC-F TC + SARC-F CC+ TC + SARC-F
Sensitivitya 31.58 (0.13–0.57) 21.05 (6.05–45.57) 21.05 (0.06–0.46) 15.79 (0.03–0.40)
Specificitya 74.26 (0.65–0.82) 98.02 (93.03–99.76) 99.01 (0.95–1.00) 99.01 (0.95–1.00)
PPVa 18.75 (0.10–0.33) 66.67 (0.28–0.91) 80 (0.32–0.97) 75 (0.25–0.96)
NPVa 85.23 (0.81–0.89) 86.84 (0.84–0.89) 86.96 (0.84–0.89) 86.21 (0.84–0.88)
LR+ 1.23 (0.59–2.57)b 10.63 (2.09–54.00)b 21.26 (2.51–179.97)b 15.95 (1.75–145.30)b
LR- 0.92 (0.66–1.28)b 0.81 (0.64–1.02)b 0.80 (0.63–1.01)b 0.85 (0.70–1.03)b
AUC 0.535 (0.39–0.68)b 0.797 (0.67–0.92)b 0.804 (0.68–0.93)b 0.862 (0.76–0.96)b
a : % (95% CI); b : 95% CI; CC : calf circumference; TC : thigh circumference; PPV : positive predictive value;  
NPV : negative predictive value; LR+ : positive likelihood ratio; LK- : negative likelihood ratio
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thigh circumference or both with SARC-F 
questionnaire cannot be used as sarcopenia 
screening tool. Even the combination of calf 
circumference and SARC-F questionnaire had a 
lower sensitivity value compared to the SARC-F 
questionnaire alone. This very high specificity 
value allows these combinations to be used as 
a sarcopenia diagnostic tool especially in health 
care facilities with limited resources. In addition 
to its high specificity, positive predictive value 
and positive likelihood ratio also increased 
significantly so that if we get the measurements 
that meet those criteria then we will be more 
convinced that the subject is indeed experiencing 
sarcopenia.
The results of our study differed from those 
obtained by Barbosa-Silva et al23 and Urzi et 
al.24 In Barbosa-Silva et al23 study, adding calf 
circumference made the sarcopenia screening 
ability of the SARC-F questionnaire became 
better as can be seen from the increase in 
sensitivity value from 33.3% (11.8-61.6) to 
66.7% (38.4-88.2) without much affecting the 
specificity from 84.2% (77.6-89.4) to 82.9% 
(76.3-88.4). Urzi et al24 who validated the 
result from Barbosa-Silva et al study in nursing 
home also got similar result with sensitivity 
77.4% (58.9-90.4) and specificity 89.8% (77.7-
96.6). While in our study, combining calf 
circumference, thigh circumference, or both 
with the SARC-F questionnaire increased its 
specificity but the opposite happened with the 
sensitivity. The disparity might be caused by 
difference in diagnostic test goals setting. In the 
study of Barbosa-Silva et al the objective is to 
evaluate combination of calf circumference and 
SARC-F questionnaire as sarcopenia screening 
tool hence they set cut-off points that have 
higher sensitivity value which are <34 cm for 
calf circumference in men, <33 cm for calf 
circumference in women, and SARC-F score 
≥1.23. Urzi et al24 validated the result from 
Barbosa-Silva et al so they used the same cut-
off points value with Barbosa-Silva.23 While in 
our study, we want to evaluate combination of 
calf circumference, thigh circumference, and 
SARC-F questionnaire as sarcopenia diagnostic 
tool, so we set cut-off points that have higher 
specificity, which are <34 for calf circumference 
in men, <29 cm for calf circumference in women, 
and SARC-F score ≥4. Other than that, in Urzi 
et al24 study they used bioelectrical impedance 
analysis (BIA) to measure muscle mass while 
in our study we used DXA. Moreover, there 
are also differences in study participants. In the 
study of Barbosa-Silva et al23 the subjects were 
the elderly population in the community and in 
the Urzi et al24 study, the research subjects were 
elderly population in nursing home, with both 
study used diagnosis criteria of sarcopenia from 
EWGSOP. In our study, the subjects were elderly 
patients in outpatient care and we used diagnosis 
criteria of sarcopenia from AWGS.
Our study was the first study that evaluate 
the diagnostic performance of combination of 
calf circumference, thigh circumference, and 
SARC-F questionnaire to detect sarcopenia. 
This study followed diagnostic criteria from 
AWGS and used DXA in measuring muscle 
mass. Several other studies with similar setting 
have been carried out but those studies used 
diagnostic criteria from EWGSOP which had 
different cut-off points measurement from 
AWGS. The limitation of our study was that 
the number of participants between male and 
female were uneven, where there were fewer 
male subjects than female subjects and this may 
contribute for the wide range of  95%CI in male 
group compared to female group.
CONCLUSION
The optimal cut-off  points  of  calf 
circumference to detect low muscle mass are 
less than 34 cm in men and less than 29 cm in 
women, while the optimal cut-off points of thigh 
circumference to detect low muscle mass are less 
than 49 cm in men and less than 44 cm in women. 
The optimal cut-off point for the SARC-F 
questionnaire score to detect a decrease in muscle 
function is 4 or more. Combination of calf 
circumference, thigh circumference and SARC-F 
questionnaire have good diagnostic accuracy to 
detect sarcopenia in patients aged 60 years or 
older and can be used as a tool for diagnosing 
sarcopenia in health services with limited 
resources. We still need external validation of 
the combination of calf circumference, thigh 
circumference and SARC-F questionnaire in the 
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126
elderly population in other secondary and tertiary 
health care to detect sarcopenia. We also suggest 
to do further study with appropriate numbers of 
participants between male and female subjects.
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